The results of our immunohistochemical studies on NSCLC TMAs revealed significantly higher mean PAK1 immunostaining scores in squamous cell carcinoma than in adenocarcinoma tissue specimens. This evidence concerns the gene PAK1 and non-small cell lung carcinoma.